Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays - PubMed (original) (raw)
Comparative Study
. 2002 Jan 17;21(3):475-8.
doi: 10.1038/sj.onc.1205111.
T Zou, Y Xu, V Shustova, J Yin, Y Mori, F Sato, S Wang, A Olaru, D Shibata, B D Greenwald, M J Krasna, J M Abraham, S J Meltzer
Affiliations
- PMID: 11821959
- DOI: 10.1038/sj.onc.1205111
Comparative Study
Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays
F M Selaru et al. Oncogene. 2002.
Abstract
In order to identify and contrast global gene expression profiles defining the premalignant syndrome, Barrett's esophagus, as well as frank esophageal cancer, we utilized cDNA microarray technology in conjunction with bioinformatics tools. We hybridized microarrays, each containing 8000 cDNA clones, to RNAs extracted from 13 esophageal surgical or endoscopic biopsy specimens (seven Barrett's metaplasias and six esophageal carcinomas). Hierarchical cluster analysis was performed on these results and displayed using a color-coded graphic representation (Treeview). The esophageal samples clustered naturally into two principal groups, each possessing unique global gene expression profiles. After retrieving histologic reports for these tissues, we found that one main cluster contained all seven Barrett's samples, while the remaining principal cluster comprised the six esophageal cancers. The cancers also clustered according to histopathological subtype. Thus, squamous cell carcinomas (SCCAs) constituted one group, adenocarcinomas (ADCAs) clustered separately, and one signet-ring carcinoma was in its own cluster, distinct from the ADCA cluster. We conclude that cDNA microarrays and bioinformatics show promise in the classification of esophageal malignant and premalignant diseases, and that these methods can be applied to small biopsy samples.
Similar articles
- Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer.
Xu Y, Selaru FM, Yin J, Zou TT, Shustova V, Mori Y, Sato F, Liu TC, Olaru A, Wang S, Kimos MC, Perry K, Desai K, Greenwald BD, Krasna MJ, Shibata D, Abraham JM, Meltzer SJ. Xu Y, et al. Cancer Res. 2002 Jun 15;62(12):3493-7. Cancer Res. 2002. PMID: 12067993 - Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma.
Greenawalt DM, Duong C, Smyth GK, Ciavarella ML, Thompson NJ, Tiang T, Murray WK, Thomas RJ, Phillips WA. Greenawalt DM, et al. Int J Cancer. 2007 May 1;120(9):1914-21. doi: 10.1002/ijc.22501. Int J Cancer. 2007. PMID: 17236199 - Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.
Stairs DB, Nakagawa H, Klein-Szanto A, Mitchell SD, Silberg DG, Tobias JW, Lynch JP, Rustgi AK. Stairs DB, et al. PLoS One. 2008;3(10):e3534. doi: 10.1371/journal.pone.0003534. Epub 2008 Oct 27. PLoS One. 2008. PMID: 18953412 Free PMC article. - Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma.
Wang XW, Gao HJ, Fang DC. Wang XW, et al. J Dig Dis. 2008 May;9(2):68-71. doi: 10.1111/j.1751-2980.2008.00324.x. J Dig Dis. 2008. PMID: 18419638 Review. - Molecular targets for treatment of Barrett's esophagus.
Feagins LA, Souza RF. Feagins LA, et al. Dis Esophagus. 2005;18(2):75-86. doi: 10.1111/j.1442-2050.2005.00465.x. Dis Esophagus. 2005. PMID: 16053481 Review.
Cited by
- Gastric adenocarcinoma: review and considerations for future directions.
Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Dicken BJ, et al. Ann Surg. 2005 Jan;241(1):27-39. doi: 10.1097/01.sla.0000149300.28588.23. Ann Surg. 2005. PMID: 15621988 Free PMC article. Review. - MicroRNA expression profiles of esophageal cancer.
Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR. Feber A, et al. J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260. doi: 10.1016/j.jtcvs.2007.08.055. Epub 2007 Dec 26. J Thorac Cardiovasc Surg. 2008. PMID: 18242245 Free PMC article. - Future directions in esophageal cancer therapy.
Wald O, Smaglo B, Mok H, Groth SS. Wald O, et al. Ann Cardiothorac Surg. 2017 Mar;6(2):159-166. doi: 10.21037/acs.2017.02.01. Ann Cardiothorac Surg. 2017. PMID: 28447005 Free PMC article. - Genomic-Wide Analysis with Microarrays in Human Oncology.
Inaoka K, Inokawa Y, Nomoto S. Inaoka K, et al. Microarrays (Basel). 2015 Oct 16;4(4):454-73. doi: 10.3390/microarrays4040454. Microarrays (Basel). 2015. PMID: 27600234 Free PMC article. Review. - Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer.
Huang CJ, Chien CC, Yang SH, Chang CC, Sun HL, Cheng YC, Liu CC, Lin SC, Lin CM. Huang CJ, et al. J Cell Mol Med. 2008 Oct;12(5B):1936-43. doi: 10.1111/j.1582-4934.2008.00253.x. Epub 2008 Feb 4. J Cell Mol Med. 2008. PMID: 18266979 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical